Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Quantitative Imaging Biomarkers of Treatment Response and Prognosis in Breast Cancer
Pathways Regulating Lung Transplant Tolerance
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Illinois Surgical Quality Improvement Conference
HPV Clearance by Folic Acid Supplementation
Recently added grants:
Development of a Neonatal Abstinence Syndrome Therapy
MRI data fusion to investigate effects of drug abuse on HIV neurological complications
Development and pilot testing of a PrEP communication intervention and integration into existing HIV testing services for female IV drug using clients of a needle exchange
Mechanisms underlying therapy failure of immune checkpoint inhibitors and Notch1 loss-mediated immunosuppression in head and neck cancers
Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67189-3-0-1
Application #
7574874
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Howard University
$308,392
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gordeuk, Victor /
$263,550
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant
